China Prepares Site For First-In-Human Studies But Safety Concerns Remain
This article was originally published in PharmAsia News
Executive Summary
Multinational companies have long urged China to allow first-in-human studies for innovative drugs developed outside the country. Now that wish could be getting close to reality.